Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361360 · ClinicalTrials.gov registry record
Permissive Hypercapnia and Brain Development in Premature Infants
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 10
- Enrollment target
NCT01361360 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 10 participants.
The verdict
NCT01361360 has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
In the US, every year approximately 30,000 infants are born very prematurely, with birth weight less than 1000 grams. These infants usually require ventilators to help them breath normally during the first few weeks of life. Although the ventilator is lifesaving, it can also injure the very fragile lungs of these infants. Thus, a ventilation strategy, called permissive hypercapnia (high carbon dioxide), is widely used to prevent lung injury. Importantly, there is new research showing that high carbon dioxide may cause brain injury. In our proposed research, we will use magnetic resonance imaging methods to evaluate the brain in 40 very premature infants at term-equivalent age (Half of them had permissive hypercapnia ventilation, the other half did not) to see if permissive hypercapnia has adverse effect on brain development.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01361360
The ClinicalTrials.gov registry entry for NCT01361360 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01361360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01361360 about?
NCT01361360 is a clinical study titled "Permissive Hypercapnia and Brain Development in Premature Infants". In the US, every year approximately 30,000 infants are born very prematurely, with birth weight less than 1000 grams. These infants usually require ventilators to help them breath normally during the first few weeks of life. Although the ventilator is lifesaving, it can also injure the very fragile ...
What is the current status of trial NCT01361360?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2011-05. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT01361360?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.